S

Shandong Boan Biotechnology Co Ltd
HKEX:6955

Watchlist Manager
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Watchlist
Price: 9.24 HKD -0.54% Market Closed
Market Cap: 5.8B HKD

Wall Street
Price Targets

Price Targets Summary
Shandong Boan Biotechnology Co Ltd

There are no price targets for Shandong Boan Biotechnology Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shandong Boan Biotechnology Co Ltd Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
16% Upside
ACIU
AC Immune SA
181% Upside
QXO
SilverSun Technologies Inc
37% Upside

Revenue
Forecast

66% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
66% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

For the last 3 years the compound annual growth rate for Shandong Boan Biotechnology Co Ltd's revenue is 66%. The projected CAGR for the next 2 years is 33%.

Operating Income
Forecast

N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
56%
Average Beat
N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
56%
Average Beat

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's operating income for the next 2 years is 36%.

Net Income
Forecast

N/A
Past Growth
75% / Year
Estimated Growth
Estimates Accuracy
-30%
Average Miss
N/A
Past Growth
75% / Year
Estimated Growth
Estimates Accuracy
-30%
Average Miss

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's net income for the next 2 years is 75%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Boan Biotechnology Co Ltd's stock price target?
Not Available

Shandong Boan Biotechnology Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Shandong Boan Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
33%

For the last 3 years the compound annual growth rate for Shandong Boan Biotechnology Co Ltd's revenue is 66%. The projected CAGR for the next 2 years is 33%.

What is Shandong Boan Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
36%

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's operating income for the next 2 years is 36%.

What is Shandong Boan Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
75%

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's net income for the next 2 years is 75%.

Back to Top